Drugs / Recombinant birch pollen
Recombinant birch pollen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00309062 | Dec 2003 → Jun 2006 | — | Allergopharma GmbH & Co. KG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant birch pollen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00309062 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant Hypoallergenic Derivative of the Major Birch Pollen Allergen” NCT00309062 ↗ |